Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin (Incepta) vs Eprex in Healthy Adults
NCT07025681Phase 3Recruiting
- Sponsor
- Incepta Pharmaceuticals Ltd.
- Start
- Apr 2025
- Primary completion
- Sep 2025
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 3 trial of epoetin alfa in anemia, sponsored by Incepta Pharmaceuticals Ltd.. Started Apr 2025; status: recruiting.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT07025681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07025681.